Zealand Pharma A/S
ZLDPF
$61.00
$3.506.09%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 121,008.05% | -11.80% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 121,008.05% | -11.80% | |||
| Cost of Revenue | 9.28% | -2.06% | |||
| Gross Profit | 127,391.11% | -12.27% | |||
| SG&A Expenses | 15.84% | -34.10% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 773.85% | 778.92% | |||
| Total Operating Expenses | 94.78% | 1.12% | |||
| Operating Income | 2,309.05% | -1.42% | |||
| Income Before Tax | 2,697.56% | -13.97% | |||
| Income Tax Expenses | 42,209.17% | -136.71% | |||
| Earnings from Continuing Operations | 2,535.43% | -13.73% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 2,535.43% | -13.73% | |||
| EBIT | 2,309.05% | -1.42% | |||
| EBITDA | 2,343.54% | -0.61% | |||
| EPS Basic | 2,531.09% | -13.95% | |||
| Normalized Basic EPS | 2,562.19% | -15.59% | |||
| EPS Diluted | 2,497.72% | -13.95% | |||
| Normalized Diluted EPS | 2,528.39% | -15.59% | |||
| Average Basic Shares Outstanding | 0.19% | -0.20% | |||
| Average Diluted Shares Outstanding | 1.58% | -0.20% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||